Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

Fig. 1

FLI1 expression in DLBCL clinical specimens and cell lines. A Differential expression of FLI1 RNA in four datasets comparing GCB DLBCL to ABC DLBCL. In the contingency tables, FLI1 mRNA expression was dichotomized into high and low values using the median as a cut-off. B Immunoblot showing protein expression of FLI1, in twelve GCB DLBCL and eight ABC DLBCL cell lines; mouse monoclonal α-GAPDH was used as loading control; quantification of FLI1 protein levels in two replicates (two-tailed T test P value = 0.046)

Back to article page